210 related articles for article (PubMed ID: 25474550)
1. AS101 prevents diabetic nephropathy progression and mesangial cell dysfunction: regulation of the AKT downstream pathway.
Shemesh II; Rozen-Zvi B; Kalechman Y; Gafter U; Sredni B
PLoS One; 2014; 9(12):e114287. PubMed ID: 25474550
[TBL] [Abstract][Full Text] [Related]
2. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
3. YAP mediates the interaction between the Hippo and PI3K/Akt pathways in mesangial cell proliferation in diabetic nephropathy.
Qian X; He L; Hao M; Li Y; Li X; Liu Y; Jiang H; Xu L; Li C; Wu W; Du L; Yin X; Lu Q
Acta Diabetol; 2021 Jan; 58(1):47-62. PubMed ID: 32816106
[TBL] [Abstract][Full Text] [Related]
4. TGFβ-stimulated microRNA-21 utilizes PTEN to orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and matrix expansion.
Dey N; Ghosh-Choudhury N; Kasinath BS; Choudhury GG
PLoS One; 2012; 7(8):e42316. PubMed ID: 22879939
[TBL] [Abstract][Full Text] [Related]
5. Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells.
Subathra M; Korrapati M; Howell LA; Arthur JM; Shayman JA; Schnellmann RG; Siskind LJ
Am J Physiol Renal Physiol; 2015 Aug; 309(3):F204-15. PubMed ID: 26041445
[TBL] [Abstract][Full Text] [Related]
6. Ursolic acid attenuates diabetic mesangial cell injury through the up-regulation of autophagy via miRNA-21/PTEN/Akt/mTOR suppression.
Lu X; Fan Q; Xu L; Li L; Yue Y; Xu Y; Su Y; Zhang D; Wang L
PLoS One; 2015; 10(2):e0117400. PubMed ID: 25689721
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal regulation of miR-214 and PTEN by high glucose regulates renal glomerular mesangial and proximal tubular epithelial cell hypertrophy and matrix expansion.
Bera A; Das F; Ghosh-Choudhury N; Mariappan MM; Kasinath BS; Ghosh Choudhury G
Am J Physiol Cell Physiol; 2017 Oct; 313(4):C430-C447. PubMed ID: 28701356
[TBL] [Abstract][Full Text] [Related]
8. LncRNA TUG1 inhibits the proliferation and fibrosis of mesangial cells in diabetic nephropathy via inhibiting the PI3K/AKT pathway.
Zang XJ; Li L; Du X; Yang B; Mei CL
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7519-7525. PubMed ID: 31539141
[TBL] [Abstract][Full Text] [Related]
9. Hydrophobic motif site-phosphorylated protein kinase CβII between mTORC2 and Akt regulates high glucose-induced mesangial cell hypertrophy.
Das F; Ghosh-Choudhury N; Mariappan MM; Kasinath BS; Choudhury GG
Am J Physiol Cell Physiol; 2016 Apr; 310(7):C583-96. PubMed ID: 26739493
[TBL] [Abstract][Full Text] [Related]
10. TGFβ acts through PDGFRβ to activate mTORC1 via the Akt/PRAS40 axis and causes glomerular mesangial cell hypertrophy and matrix protein expression.
Maity S; Das F; Kasinath BS; Ghosh-Choudhury N; Ghosh Choudhury G
J Biol Chem; 2020 Oct; 295(42):14262-14278. PubMed ID: 32732288
[TBL] [Abstract][Full Text] [Related]
11. Deacetylation of S6 kinase promotes high glucose-induced glomerular mesangial cell hypertrophy and matrix protein accumulation.
Das F; Maity S; Ghosh-Choudhury N; Kasinath BS; Ghosh Choudhury G
J Biol Chem; 2019 Jun; 294(24):9440-9460. PubMed ID: 31028173
[TBL] [Abstract][Full Text] [Related]
12. Role of growth arrest-specific gene 6 in diabetic nephropathy.
Arai H; Nagai K; Doi T
Vitam Horm; 2008; 78():375-92. PubMed ID: 18374201
[TBL] [Abstract][Full Text] [Related]
13. Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL/6 mice with streptozotocin-induced type I diabetic nephropathy.
Yung S; Chau MK; Zhang Q; Zhang CZ; Chan TM
PLoS One; 2013; 8(1):e54501. PubMed ID: 23349910
[TBL] [Abstract][Full Text] [Related]
14. GdCl
Li J; Wu B; Hu H; Fang X; Liu Z; Wu S
J Pharmacol Sci; 2020 Feb; 142(2):41-49. PubMed ID: 31831259
[TBL] [Abstract][Full Text] [Related]
15. Mesangial cell hypertrophy by high glucose is mediated by downregulation of the tumor suppressor PTEN.
Mahimainathan L; Das F; Venkatesan B; Choudhury GG
Diabetes; 2006 Jul; 55(7):2115-25. PubMed ID: 16804083
[TBL] [Abstract][Full Text] [Related]
16. The mTOR promotes oxidative stress-induced apoptosis of mesangial cells in diabetic nephropathy.
Lu Q; Zhou Y; Hao M; Li C; Wang J; Shu F; Du L; Zhu X; Zhang Q; Yin X
Mol Cell Endocrinol; 2018 Sep; 473():31-43. PubMed ID: 29277549
[TBL] [Abstract][Full Text] [Related]
17. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy.
Nagai K; Matsubara T; Mima A; Sumi E; Kanamori H; Iehara N; Fukatsu A; Yanagita M; Nakano T; Ishimoto Y; Kita T; Doi T; Arai H
Kidney Int; 2005 Aug; 68(2):552-61. PubMed ID: 16014032
[TBL] [Abstract][Full Text] [Related]
18. Combination of leflunomide and benazepril reduces renal injury of diabetic nephropathy rats and inhibits high-glucose induced cell apoptosis through regulation of NF-κB, TGF-β and TRPC6.
Li H; Wang Y; Zhou Z; Tian F; Yang H; Yan J
Ren Fail; 2019 Nov; 41(1):899-906. PubMed ID: 31552773
[No Abstract] [Full Text] [Related]
19. XBP1 inhibits mesangial cell apoptosis in response to oxidative stress via the PTEN/AKT pathway in diabetic nephropathy.
Wang Y; He Z; Yang Q; Zhou G
FEBS Open Bio; 2019 Jul; 9(7):1249-1258. PubMed ID: 31077568
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA NEAT1 accelerates the proliferation and fibrosis in diabetic nephropathy through activating Akt/mTOR signaling pathway.
Huang S; Xu Y; Ge X; Xu B; Peng W; Jiang X; Shen L; Xia L
J Cell Physiol; 2019 Jul; 234(7):11200-11207. PubMed ID: 30515796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
